Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0KQ
|
|||
Former ID |
DNC006595
|
|||
Drug Name |
(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone
|
|||
Synonyms |
CHEMBL210425; (1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C23H16N2O2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)OC2=CC3=C(C=C2)NC(=C3)C(=O)C4=CC5=CC=CC=C5N4
|
|||
InChI |
1S/C23H16N2O2/c26-23(21-13-15-6-4-5-9-19(15)24-21)22-14-16-12-18(10-11-20(16)25-22)27-17-7-2-1-3-8-17/h1-14,24-25H
|
|||
InChIKey |
XSKBJPGCRXDUEV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase. J Med Chem. 2006 Jun 1;49(11):3101-15. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.